📣 Today at the German Cancer Congress, @eortc.org #QualityofLife Group highlights 3 important PRO projects: K. Taylor on #HNC survivorship; T. Nordhausen on TCIs for EORTC lung cancer module & PRO implementation in routine care. www.deutscher-krebskongress.de #DKK2026 @krebsgesellschaft.bsky.social

Over the past weeks, we shared stories from patients, advocates & researchers shaped by academic cancer research. Thank you for following this journey. Together we can advance research and improve survival & quality of life. Get involved 👉 www.eortc.org/impact #WorldCancerDay #EORTCimpact

💪The 2025 American Thyroid Assoc. Guidelines for differentiated #ThyroidCancer highlight the importance of validated #QualityofLife measures & potential of the @eortc.org QLQ-THY34, a thyroid-specific tool, to provide important insights into patients’ psychosocial well-being. doi.org/10.1177/1050...

Happy International Day of Women & Girls in Science! At EORTC, we celebrate the women advancing cancer research. 💡 Prof Piccart helped lead MINDACT, transforming breast cancer care and reducing unnecessary chemotherapy. Find out more: www.eortc.org/impact/ #EORTCimpact

👉 In case you missed it, we’ve created a new webpage dedicated to EORTC’s impact over the last 60 years. Discover more: www.eortc.org/impact #WorldCancerDay #ClinicalTrials #EORTCimpact #CancerResearch #LeavingNoCancerPatientBehind

🎗️ #WorldCancerDay reminds us that every patient’s experience matters, like Betty's. We work to improve the #QualityofLife of people living with cancer through robust patient-reported outcome measures—leading to better understanding of treatment impact and better care. #GivingVoice2Patients 👇

👏 Recently published in Pediatric Blood & Cancer: SIOP abstract by Chiara Vetrano about @eortc.org #QualityofLife Group systematic review mapping key HRQOL aspects for children with cancer under 8 years to refine PRO assessment in this population. 🔗 doi.org/10.1002/pbc.... #GivingVoice2Patients

Why do academic #ClinicalTrials matter? Because they show which treatments truly benefit patients. Roger, an EORTC trial participant, shares why independent, non‑commercial cancer research is essential. 👉 Like & reshare to spread the word. #WorldCancerDay #EORTCimpact#LeavingNoCancerPatientBehind

🤝 This multinational trial shows that @eortc.org patient-reported outcome (PRO) data provide value in the evaluation of the side effects of cancer treatment—especially for cognitive & psychological symptoms. www.eortc.org/blog/2026/01... #GivingVoice2Patients #QualityofLife @msztankay.bsky.social

📣 Registration is now open for the @eortc.org #QualityofLife Group (QLG) spring meeting 2026. 📅 16-17 April 📍 Berlin, Germany 🔗 Registration link sent to all EORTC QLG members by email today ✉️ 🔎 More info on venue, programme, etc, available here: www.eortc.org/event/eortc-... #QLGmeeting

📄Findings of a new @eortc.org #QualityofLife publication in Critical Reviews in Oncology/Hematology highlight the need for improved reporting & greater prioritisation of PRO completion regardless of trial design. 🔗 doi.org/10.1016/j.cr... #GivingVoice2Patients #CancerResearch @msztankay.bsky.social

✨ Adolescents & young adults with cancer face unique challenges – education, careers, relationships, finances & life goals. This new @eortc.org #HRQoL questionnaire was developed to better capture these realities 👇 www.eortc.org/blog/2026/01... #GivingVoice2Patients @sotonhsciences.bsky.social

📢 Don’t miss the EORTC webinar Patient Preferences Matter, happening this Friday, 9 January 2026. 🔗 For more information: www.eortc.org/event/joint-... #PatientPreferences #CancerResearch #EORTC #ClinicalTrials

📘 Just published: M Petersen et al. evaluated the use of cross-domain prediction to tailor start item selection in the @eortc.org CAT Core. Results suggest improved measurement precision for short computer-adaptive tests (CATs). 👉 doi.org/10.1007/s111... #QualityofLife @mogensgroenvold.bsky.social

📣 Upcoming @eortc.org webinar with Older Adult Council (OAC) & EORTC #QualityofLife Group: it will explore why listening to patients, especially older adults, matters in cancer research. 🗓 Jan 9, 2026 | 17:00–18:30 CET 🔗 More info: www.eortc.org/event/joint-... #CancerResearch #ClinicalTrials

🚨 Publication alert! A new international study validates the @eortc.org #QualityofLife PATSAT-C33 & OUT-PATSAT7 questionnaires as robust tools for measuring patient satisfaction in cancer care. 🌟 📰 Access the paper: doi.org/10.1186/s128... #GivingVoice2Patients #CancerResearch @miekevhr.bsky.social

This #GivingTuesday, we thank every donor & supporter for helping us stand behind patients, #LeavingNoCancerPatientBehind. Your generosity powers smarter, fairer cancer research. Donate: donate.eortcresearchfund.org/eoy/~my-dona... 🎥Watch & see why your support matters: youtu.be/QzQ2_CnwpDM #ECRF

👏EORTC joined the #ALTHEA Consortium at the IEO Europe to advance digital psychological support for cancer patients&families. Our @qol.eortc.org experts Lotte Van der Weijst & @miekevhr.bsky.social shared insights on EORTC advances in QoL&mental health assessment👇 health.ec.europa.eu/non-communic...

👏 Proud to be part of this important initiative, and to work together on improving how we capture and use patient perspectives in cancer trials. 📰 More about the new SISAQOL-IMI publication & online resources: www.eortc.org/blog/2025/11... #QualityofLife #GivingVoice2Patients @eortc.org

👏 Great poster by Tom Bootsma & Amirun Rahmat at #EuropeanCancerSummit on @eortc.org #QualityofLife (QoL) review underscoring the need to prioritise development & implementation of tailored QoL questionnaires that capture the lived experiences of LGBTQIA+ cancer patients. @europeancancer.bsky.social

📣Attending WFNOS/ #SNO2025 this week? Don't miss the rapid oral & poster presentations by @eortc.org #QualityofLife Group member Ogechukwu A. Asogwa tomorrow & Saturday on health-related quality of life in molecular glioma subtypes 👇 www.soc-neuro-onc.org/SNO2025 #NeuroOncology @neuroonc.bsky.social

👏 EORTC is glad to participate in the European Cancer Organisation Summit listening to leading experts on shaping the future of cancer care in Europe. #EuropeanCancerSummit #CancerResearch

🌟 Looking forward to the upcoming SISAQOL-IMI publication 👇 #QualityofLife #GivingVoice2Patients #CancerResearch @eortc.org

👏 Earlier today at ISPOR Europe, our CEO Denis Lacombe moderated the plenary session “Pragmatic Trials — Bridging Research and Real-World Care”. 🔗 Read more: www.eortc.org/blog/2025/11... #ISPOR #ClinicalResearch #EORTC #CancerCare #PragmaticTrials

👏 Looking forward to @eortc.org presentations this week at #ISPOREurope, including from #QualityofLife colleague Claire Piccinin on the use of EORTC item lists in industry-sponsored studies over a 3-year period, with highlights of study attributes and trends. More info 👇 #GivingVoice2Patients

🤝 As we close #PatientDays 2025, we reflect on the powerful exchanges that took place. This event reaffirmed the importance of integrating patient perspectives into research and care. Thank you to all who contributed to this meaningful dialogue. #CancerResearch #ClinicalTrials

🎉 What a day at #EORTC #PatientDays! Day 1 was packed with energy, empathy and honest round table talks. Thanks to all who joined, your voices are shaping the future of cancer care. 👋 See you tomorrow! 🔗https://www.eortc.org/event/patient-days-2025/?tab=1 #CancerCare #PatientEngagement #Oncology

🤝 EORTC #PatientDays kicks off today in Brussels! Patients, caregivers & advocates meet Europe’s top cancer researchers to shape better treatment, care & quality of life. 🔗 Learn more: www.eortc.org/event/patien... #CancerResearch #Oncology #ClinicalTrials

📢 Attending #DGHO2025? Our @eortc.org #QualityofLife Group (QLG) member Bernhard Holzner is presenting an update on the QLG CTCAEplusPRO project. 🎖️ And it was selected as one of the best abstracts 👏 www.jahrestagung-haematologie-onkologie.com #GivingVoice2Patients #DGHO #CancerResearch

👏 Today & tomorrow at #ISOQOL 2025, @eortc.org #QualityofLife Group & colleagues will present 4 posters, exploring topics like ePRO implementation, side-effect burden measurement, and creating the PRO-AE inventory. 🔍 Learn more: www.eortc.org/blog/2025/10... #GivingVoice2Patients #CancerResearch

🎤 Attending #ISOQOL 2025? Today, Kim Cocks will deliver an oral presentation on the update of the @eortc.org QLQ-MY20 module for multiple myeloma. 📅 Thurs 23 Oct, 13:50 CT, Session 102: Hematology Read more ➡️ www.eortc.org/blog/2025/10... #QualityofLife #GivingVoice2Patients #CancerResearch

📣 Exciting news! @eortc.org, through its #QualityofLife (QoL) Group, is supporting #ISOQOL 2025 and will share insights into its latest QoL research through a series of impactful abstracts presented at the conference. Learn more 👇 www.eortc.org/blog/2025/10... #GivingVoice2Patients #CancerResearch

🙌 That’s a wrap on #ESMO25! EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation. Thanks to all collaborators and patients who make this work possible. 🔗 Full summary: www.eortc.org/blog/2025/10... #CancerResearch #ClinicalTrials

👋 Attending #SIOPCongress this week? 📢 Catch tomorrow's presentation by @eortc.org #QualityofLife Group (QLG) member Anne-Sophie Darlington about a new EORTC QLG questionnaire aimed to measure all QoL issues of relevance and importance to AYAs aged 14-39 years with cancer. @worldsiop.bsky.social

👏 Congratulations to our @eortc.org #QualityofLife Group members Veronika Engele & Louis Fox for their great presentations at #ESMO25. 🏅 And well done Veronika Engele for winning the ESMO 2025 Best Poster for Psycho-oncology! 💪 #CancerResearch #GivingVoice2Patients @kingscollegelondon.bsky.social

CSO was at #ESMO2025 today, hosting a symposium to discuss our work in advancing patient-centred cancer care, and how best to engage colleagues and the broader community in Europe and beyond. #CommonSenseOncology #CancerCare

@winettevandergraaf.bsky.social @qol.eortc.org @rachriechelmann.bsky.social @madelinepe.bsky.social

👉 We continue this exciting day at #ESMO25 with a spotlight on patient engagement! Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes. 📢 Don't miss it! #Oncology #PatientEngagement #EORTC

👏 Well done to Denis Lacombe for a compelling session today at #ESMO25! Together, we’re shaping a future of cancer research that’s smarter and more inclusive. #EORTC #CancerResearch #DEI #ClinicalTrials @myesmo.bsky.social

Today at #ESMO25, EORTC CEO Denis Lacombe speaks on two key challenges in cancer research: ➡️ Are we using therapies optimally in real-world care? ➡️ Are clinical trials truly inclusive of all patients? Two sessions, one goal: research that’s both effective and equitable. #ClinicalTrials #DEI

👏 Huge congrats to Madeline Pe for her fantastic presentation at #ESMO25! Sharing key outcomes from the SISAQOL-IMI initiative and putting patient voices at the heart of cancer research. Proud moment for EORTC! 📸 #QualityOfLife #EORTC #CancerResearch #GivingVoice2Patients @qol.eortc.org

💪 Looking forward to the presentation by @madelinepe.bsky.social on the SISAQOL-IMI initiative shortly at #ESMO25! #QualityofLife #GivingVoice2Patients @eortc.org

ESMO 2025: A leadership moment! EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action. Sharing ideas, energy, and a vision for better cancer care across Europe. Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.

📍We are in Berlin for #ESMO25. Come and visit us at our booth #S4040. Don't miss EORTC's upcoming sessions, mini-oral sessions, posters and more. Stay tuned! 👉 More info: www.eortc.org/blog/2025/10... @myesmo.bsky.social #EORTC #ClinicalTrials #CancerResearch #Oncology #TreatmentOptimisation

🎤 Proud moment for the @eortc.org #QualityofLife Group at #ESMO25! Our members are sharing key insights on patient-reported outcomes & quality of life in #CancerResearch — advancing how we measure what truly matters to patients. Don’t miss their presentations 👇 www.eortc.org/blog/2025/10...

👏 Looking forward to the presentations from @eortc.org #QualityofLife Group members Ogechukwu Edeh-Asogwa & Josien Scheepens this week at @eanoassociation.bsky.social 2025! More info 👇 www.eortc.org/blog/2025/10... #EANO2025 #NeuroOncology #CancerResearch #GivingVoice2Patients

🎀 Supporting #PinkOctober & progress in #BreastCancer care. 👏 We are proud to have contributed to the update of the QLQ-BR23 into the QLQ-BR42, advancing how breast cancer patients' #QualityofLife is measured. 🔗 Learn more about @eortc.org's work & #EBCC15: www.eortc.org/blog/2025/10...

🌟 Looking forward to the @csoncol.bsky.social symposium at #ESMO2025 and to the contributions from @eortc.org President @winettevandergraaf.bsky.social and our EORTC colleagues @madelinepe.bsky.social and Chris Cronin 👏 More info 👇 #GivingVoice2Patients #CancerResearch #QualityofLife

📅 Save the date for the next @eortc.org #QualityofLife Group meeting! Our spring 2026 meeting will take place on 16 & 17 April in Berlin ✨ 🔎 More info incl. on programme and registration will be made available in early 2026 here: www.eortc.org/event/eortc-... #QLGmeeting #GivingVoice2Patients

🚀 Our Annual Newsletter is out! This year's edition features the growing role of Health Economics & HTA within the @eortc.org #QualityofLife (QoL) Group & QoL Department. 💬 It also includes inspiring insights from long-standing members. 📖 Read more: qol.eortc.org/newsletters/ #GivingVoice2Patients